{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:32:11Z","timestamp":1756463531167,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12328-017-0714-7","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T06:15:38Z","timestamp":1486102538000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7157-5352","authenticated-orcid":false,"given":"Hajime","family":"Anjiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Mukaisho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kadomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisakazu","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diem Thi-Ngoc","family":"Vo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"714_CR1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/gut.2009.182089","volume":"59","author":"AF Goddard","year":"2010","unstructured":"Goddard AF, Badreldin R, Pritchard DM, et al. British Society of Gastroenterology. The management of gastric polyps. Gut. 2010;59:1270\u20136.","journal-title":"Gut."},{"key":"714_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000478-200104000-00010","volume":"25","author":"SC Abraham","year":"2001","unstructured":"Abraham SC, Singh VK, Yardley JH, et al. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25:500\u20137.","journal-title":"Am J Surg Pathol"},{"key":"714_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000074516","volume":"68","author":"T Ohkusa","year":"2003","unstructured":"Ohkusa T, Miwa H, Hojo M, et al. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion. 2003;68:57\u201362.","journal-title":"Digestion."},{"key":"714_CR4","first-page":"714","volume":"91","author":"GG Ginsberg","year":"1996","unstructured":"Ginsberg GG, Al-Kawas FH, Fleischer DE, et al. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol. 1996;91:714\u20137.","journal-title":"Am J Gastroenterol"},{"key":"714_CR5","first-page":"1016","volume":"82","author":"M Daibo","year":"1987","unstructured":"Daibo M, Itabashi M, Hirota T. Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol. 1987;82:1016\u201325.","journal-title":"Am J Gastroenterol"},{"key":"714_CR6","first-page":"107","volume":"40","author":"J Rattan","year":"1993","unstructured":"Rattan J, Arber N, Tiomny E, et al. Gastric polypoid lesions\u2014an 8-year study. Hepatogastroenterology. 1993;40:107\u20139.","journal-title":"Hepatogastroenterology"},{"key":"714_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00428-005-0068-2","volume":"448","author":"K Dirschmid","year":"2006","unstructured":"Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448:80\u20134.","journal-title":"Virchows Arch"},{"key":"714_CR8","first-page":"2152","volume":"90","author":"J Orlowska","year":"1995","unstructured":"Orlowska J, Jarosz D, Pachlewski J, et al. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol. 1995;90:2152\u20139.","journal-title":"Am J Gastroenterol"},{"key":"714_CR9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/BF00187948","volume":"9","author":"K Hizawa","year":"1995","unstructured":"Hizawa K, Fuchigami T, Iida M, et al. Possible neoplastic transformation within gastric hyperplastic polyp. Application of endoscopic polypectomy. Surg Endosc. 1995;9:714\u20138.","journal-title":"Surg Endosc."},{"key":"714_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF02093832","volume":"41","author":"WL Zea-Iriarte","year":"1996","unstructured":"Zea-Iriarte WL, Sekine I, Itsuno M, et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci. 1996;41:377\u201386.","journal-title":"Dig Dis Sci."},{"key":"714_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0016-5107(92)70481-7","volume":"38","author":"EG Cristallini","year":"1992","unstructured":"Cristallini EG, Ascani S, Bolis GB. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc. 1992;38:481\u20134.","journal-title":"Gastrointest Endosc"},{"key":"714_CR12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/bjs.1800730705","volume":"73","author":"E Harju","year":"1986","unstructured":"Harju E. Gastric polyposis and malignancy. Br J Surg. 1986;73:532\u20133.","journal-title":"Br J Surg"},{"key":"714_CR13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2013.03.019","volume":"11","author":"YH Shaib","year":"2013","unstructured":"Shaib YH, Rugge M, Graham DY, et al. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol. 2013;11:1374\u201384.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"714_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/gastro\/gov004","volume":"3","author":"S Dacha","year":"2015","unstructured":"Dacha S, Razvi M, Massaad J, et al. Hypergastrinemia. Gastroenterol Rep (Oxf). 2015;3:201\u20138.","journal-title":"Gastroenterol Rep (Oxf)."},{"key":"714_CR15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1046\/j.1365-2036.2002.01292.x","volume":"16","author":"S Warrington","year":"2002","unstructured":"Warrington S, Baisley K, Boyce M, et al. Effects of rabeprazole, 20\u00a0mg, or esomeprazole, 20\u00a0mg, on 24-h intragastric pH and serum gastrin in healthy subjects. Aliment Pharmacol Ther. 2002;16:1301\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"714_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000199786","volume":"41","author":"E Solcia","year":"1988","unstructured":"Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988;41:185\u2013200.","journal-title":"Digestion."},{"key":"714_CR17","first-page":"273","volume":"71","author":"C Bordi","year":"1998","unstructured":"Bordi C, D\u2019Adda T, Azzoni C, et al. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med. 1998;71:273\u201384.","journal-title":"Yale J Biol Med."},{"key":"714_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/348761","author":"K Furumoto","year":"2010","unstructured":"Furumoto K, Kojima H, Okuno M, et al. Gastric carcinoid with hypergastrinemia: report of three cases. Case Rep Med. 2010. doi: 10.1155\/2010\/348761 .","journal-title":"Case Rep Med."},{"key":"714_CR19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/apt.12012","volume":"36","author":"CS Jianu","year":"2012","unstructured":"Jianu CS, Fossmark R, Viset T, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther. 2012;36:644\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"14","key":"714_CR20","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3748\/wjg.14.1646","volume":"21","author":"R Fossmark","year":"2008","unstructured":"Fossmark R, Qvigstad G, Waldum HL. Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol. 2008;21(14):1646\u201351.","journal-title":"World J Gastroenterol"},{"key":"714_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/975479","author":"R Fossmark","year":"2011","unstructured":"Fossmark R, Qvigstad G, Martinsen TC, et al. Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis. J Biomed Biotechnol. 2011. doi: 10.1155\/2011\/975479 .","journal-title":"J Biomed Biotechnol."},{"key":"714_CR22","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s10620-014-3468-9","volume":"60","author":"HL Waldum","year":"2015","unstructured":"Waldum HL, Hauso \u00d8, S\u00f8rdal \u00d8F, et al. Gastrin may mediate the carcinogenic effect of helicobacter pylori infection of the stomach. Dig Dis Sci. 2015;60:1522\u20137.","journal-title":"Dig Dis Sci"},{"key":"714_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijc.1460","volume":"94","author":"S Tsukashita","year":"2001","unstructured":"Tsukashita S, Kushima R, Bamba M, et al. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer. 2001;94:166\u201370.","journal-title":"Int J Cancer"},{"key":"714_CR24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/his.12208","volume":"63","author":"R Nishimura","year":"2013","unstructured":"Nishimura R, Mukaisho K, Yamamoto H, et al. Precursor-derived versus de-novo carcinogenesis depends on lineage-specific mucin phenotypes of intramucosal gland-forming gastric neoplasms. Histopathology. 2013;63:616\u201329.","journal-title":"Histopathology"},{"key":"714_CR25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygeno.2005.09.019","volume":"87","author":"SE Little","year":"2006","unstructured":"Little SE, Vuononvirta R, Reis-Filho JS, et al. Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics. 2006;87:298\u2013306.","journal-title":"Genomics"},{"key":"714_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-015-0080-6","author":"DT Vo","year":"2015","unstructured":"Vo DT, Nakayama T, Yamamoto H, et al. Progression risk assessments of individual non-invasive gastric neoplasms by genomic copy-number profile and mucin phenotype. BMC Med Genom. 2015. doi: 10.1186\/s12920-015-0080-6 .","journal-title":"BMC Med Genom"},{"key":"714_CR27","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1073\/pnas.0407979101","volume":"101","author":"MT Barrett","year":"2004","unstructured":"Barrett MT, Scheffer A, Ben-Dor A, et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA. 2004;101:17765\u201370.","journal-title":"Proc Natl Acad Sci USA."},{"key":"714_CR28","first-page":"146","volume":"33","author":"M Stolte","year":"1995","unstructured":"Stolte M, Bethke B, Seifert E, et al. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol. 1995;33:146\u20139.","journal-title":"Z Gastroenterol"},{"key":"714_CR29","first-page":"134","volume":"30","author":"M Stolte","year":"1992","unstructured":"Stolte M, Bethke B, R\u00fchl G, et al. Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol. 1992;30:134\u20138.","journal-title":"Z Gastroenterol"},{"issue":"16","key":"714_CR30","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3748\/wjg.v16.i19.2323","volume":"21","author":"AB Thomson","year":"2010","unstructured":"Thomson AB, Sauve MD, Kassam N, et al. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010;21(16):2323\u201330.","journal-title":"World J Gastroenterol"},{"key":"714_CR31","first-page":"296","volume":"40","author":"NE Montemurro","year":"1993","unstructured":"Montemurro NE, Di Maggio A, Loperfido A, et al. Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study. Clin Nephrol. 1993;40:296\u20138.","journal-title":"Clin Nephrol."},{"key":"714_CR32","first-page":"449","volume":"16","author":"L Eslami","year":"2013","unstructured":"Eslami L, Nasseri-Moghaddam S. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions? Arch Iran Med. 2013;16:449\u201358.","journal-title":"Arch Iran Med."},{"key":"714_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"H Song","year":"2014","unstructured":"Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev. 2014. doi: 10.1002\/14651858 .","journal-title":"Cochrane Database Syst Rev"},{"key":"714_CR34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.2010.207662","volume":"60","author":"T Hagiwara","year":"2011","unstructured":"Hagiwara T, Mukaisho K, Nakayama T, et al. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut. 2011;60:624\u201330.","journal-title":"Gut"},{"key":"714_CR35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00535-010-0207-7","volume":"45","author":"M Hongo","year":"2010","unstructured":"Hongo M, Fujimoto K, Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010;45:618\u201324.","journal-title":"J Gastroenterol"},{"key":"714_CR36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/00365521.2011.627444","volume":"47","author":"CS Jianu","year":"2012","unstructured":"Jianu CS, Lange OJ, Viset T, et al. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor. Scand J Gastroenterol. 2012;47:64\u20137.","journal-title":"Scand J Gastroenterol"},{"key":"714_CR37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.9738\/INTSURG-D-14-00074.1","volume":"100","author":"H Yamauchi","year":"2015","unstructured":"Yamauchi H, Sakurai S, Nakazawa N, et al. A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia. Int Surg. 2015;100:562\u20137.","journal-title":"Int Surg"},{"key":"714_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(73)80087-3","volume":"64","author":"JE McGuigan","year":"1973","unstructured":"McGuigan JE, Trudeau WL. Serum and tissue gastrin concentrations in patients with carcinoma of the stomach. Gastroenterology. 1973;64:22\u20135.","journal-title":"Gastroenterology"},{"key":"714_CR39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/apm.12380","volume":"123","author":"R Fossmark","year":"2015","unstructured":"Fossmark R, Sagatun L, Nordrum IS, et al. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival. APMIS. 2015;123:509\u201314.","journal-title":"APMIS."},{"key":"714_CR40","first-page":"1916","volume":"88","author":"GY Lauwers","year":"1993","unstructured":"Lauwers GY, Wahl SJ, Melamed J, et al. p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol. 1993;88:1916\u20139.","journal-title":"Am J Gastroenterol"},{"key":"714_CR41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1649::AID-CNCR5>3.0.CO;2-N","volume":"86","author":"AM Nogueira","year":"1999","unstructured":"Nogueira AM, Carneiro F, Seruca R, et al. Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer. 1999;86:1649\u201356.","journal-title":"Cancer"},{"key":"714_CR42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1309\/VLF5-UCNH-XQM2-X410","volume":"115","author":"K Murakami","year":"2001","unstructured":"Murakami K, Mitomi H, Yamashita K, et al. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1\/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115:224\u201334.","journal-title":"Am J Clin Pathol"},{"key":"714_CR43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-009-0814-y","volume":"455","author":"TE Buffart","year":"2009","unstructured":"Buffart TE, van Grieken NC, Tijssen M, et al. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch. 2009;455:213\u201323.","journal-title":"Virchows Arch"},{"key":"714_CR44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3892\/ol.2014.1849","volume":"7","author":"JU Kang","year":"2014","unstructured":"Kang JU. Chromosome 8q as the most frequent target for amplification in early gastric carcinoma. Oncol Lett. 2014;7:1139\u201343.","journal-title":"Oncol Lett."},{"key":"714_CR45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.38.6.622","volume":"38","author":"T Hattori","year":"1985","unstructured":"Hattori T. Morphological range of hyperplastic polyps and carcinomas arising inhyperplastic polyps of the stomach. J Clin Pathol. 1985;38:622\u201330.","journal-title":"J Clin Pathol"},{"key":"714_CR46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10120-006-0381-8","volume":"9","author":"R Kushima","year":"2006","unstructured":"Kushima R, Vieth M, Borchard F, et al. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer. 2006;9:177\u201384.","journal-title":"Gastric Cancer"},{"key":"714_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01200733","volume":"120","author":"R Kushima","year":"1993","unstructured":"Kushima R, Hattori T. Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol. 1993;120:103\u201311.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-017-0714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-017-0714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-017-0714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T07:18:29Z","timestamp":1719040709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-017-0714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1007\/s12328-017-0714-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}